Special Report
Click for Home


Glaucoma Drainage Implants in Asian Eyes

T Aung
Singapore National Eye Centre,
Singapore

 

Modern microsurgical techniques have increased the success rate of conventional filtration surgery in most patients with glaucoma to 80 to 90%. However, previous studies have suggested that there are racial differences in the outcome of conventional filtration surgery with Asian patients reported to have poorer surgical outcomes than Caucasians. No studies have examined the outcome of glaucoma drainage implants in Asian eyes. This study was designed to assess the outcome of glaucoma drainage implants in Asian eyes and to determine whether there are racial differences compared with previous reports in Caucasian patients.

Materials and Methods

83 Asian patients (83 eyes) who underwent glaucoma drainage implant surgery at the Singapore National Eye Centre from 1 January 1993 to 31 August 1996 were included in the review.

Table 1. Racial origins of patients receiving glaucoma drainage implant surgery

Chinese
66
Malay
9
Indian
6
Other Asian Race
2

Table 1 shows the racial origins of the patients included in the study. All patients had complicated glaucoma, defined as "those patients who previously have failed conventional medical, laser, or nonseton surgical treatment, or some combination thereof." The diagnoses of these patients are shown in table 2.

Table 2 . Diagnoses of patients receiving glaucoma drainage implants

Diagnosis 

Number eyes


Neovascular glaucoma
35
Post-traumatic glaucoma
12
Post-corneal graft glaucoma
9
Pseudophakic glaucoma
7
Uveitic glaucoma
7
Primary open angle glaucoma (with previously failed trabeculectomy)
4
Post-vitrectomy glaucoma
3
Iridocorneal endothelial syndrome
2
Congenital glaucoma
2
Chronic angle closure glaucoma
2

Two types of drainage implant were used in the study 29 Molteno implants and 54 Baerveldt implants. The model was chosen at the discretion of the surgeon in a non-randomised fashion. A single stage procedure was performed and the postoperative management was similar for all patients. The sites for implant fixation included the supertemporal quadrant, superonasal quadrant, inferonasal quadrant, and inferotemporal quadrant. The site was chosen according to factors such as scleral thinning, conjunctival scarring, accessibility of the orbit, presence of peripheral anterior synechiae and depth of the anterior chamber.

Topical tobramycin, prednisolone forte and homatropine were given routinely for the first 6 postoperative weeks. Intraocular pressure (IOP) was measured with a Goldmann applanation tonometer at each visit and antiglaucoma medication was added, as required, to supplement pressure reduction. Outcome was assessed in terms of IOP, visual acuity, and the incidence of complications. The IOP criteria for success were as follows:

  • complete success IOP < 22 mm Hg without medication
  • qualified success IOP < 22 mm Hg with 1 or more medications
  • failure IOP 22 mm Hg with or without medication.

The follow-up period ranged from 6 to 40 months (mean 13.41 months).

Results

The mean IOP was reduced from 40.43 ± 9.72 mm Hg (range 18-68 mm Hg) to 14.16 ± 6.29 mm Hg after surgery. 71 patients (85.5%) achieved a final IOP of < 22 mm Hg, of whom 61 patients did not require medication and were classified as a complete success (table 3). The remaining 10 patients who acquired an IOP of < 22 mm Hg with medication were considered to be qualified successes. The remaining 12 patients, including 6 who lost light perception, were classified as failures.

The final best corrected visual acuity improved for 22 patients, remained the same for 49 patients and worsened for 12 patients compared with the pre- operative baseline (table 3).

Table 3 . Success rates following glaucoma drainage implant surgery according to intraocular pressure (IOP) reduction and visual acuity

IOP reduction
Visual acuity






Outcome 
Number (%) 
Outcome 
Number (%)  

Complete success
61 (73.5)
Improvement
22 (26.5)
Qualified success
10 (12)
No change
49 (59)
Failure
12 (14.5)
Deterioration
12 (14.5)

Table 4 . Success rates for the Baerveldt and Molteno implants

 
Baerveldt Implant
Molteno Implant
 
 

Outcome
250 mm2
(n = 30)
350 mm2
(n = 24)
Single plate
(n = 12)
Double plate
(n = 17)






Success
24
21
8
8
Qualified success
2
2
2
4
Failure
4
1
2
5

 

The Baerveldt implant had a better outcome than the Molteno implant in terms of IOP control. There were 45 (83.3%) successes among 54 patients receiving the Baerveldt implant compared with 16 (55.2%) successes among the 29 patients given the Molteno implant (table 4). There were no intra-operative complications, although postoperative complications occurred in 46 eyes and 20 eyes required surgical revision.

Discussion

Glaucoma drainage implants have gained widespread acceptance for the treatment of severe recalcitrant glaucoma. For many patients they offer the only alternative to cyclodestructive procedures to the ciliary body. The drainage implants used in this study resulted in satisfactory IOP control for the majority of patients with or without additional medication, and the visual acuity outcomes were encouraging. Clinical failure of drainage implants to adequately control IOP is likely to be due to remodelling of the fibrous capsule with thickening, resulting in loss of permeability, diminished aqueous drainage and failure of satisfactory bleb formation. Failure may also be related to alteration of the position of the implant. The results of this study compare well with other trials using drainage implants in terms of both IOP control and visual acuity. Importantly, these results were obtained in an Asian population, showing that drainage implants can be successful in this racial group, and were comparable with the success rates achieved in studies of non-Asian patients.

Conclusion

Glaucoma drainage implants are successful in Asian eyes for the treatment of refractory glaucoma. The implants are well tolerated and achieve stable IOP reduction. There is also satisfactory visual stabilisation. "The role of these implants in Asian eyes for treatment of complicated glaucoma with failed conventional treatment, or for glaucoma unlikely to respond to conventional drainage surgery, indeed is promising."

Further Reading

1. Aung T, Seah SKL. Glaucoma drainage implants in Asian eyes. Ophthalmology 1998;106:2117-2122.

This summary was written by a staff medical reporter.

 


Set the Agenda for Your Journal

As practising ophthalmologists in the Asia-Pacific region, Asian Journal of OPHTHALMOLOGY is your Journal. Asian Journal of OPHTHALMOLOGY is intended to be a vehicle for the exchange of information relevant to clinical practice in Asia. Make the Journal work for you by sending your letters, contributions, articles, meeting reports and announcements, and any other information that may interest your colleagues. By telling us what you would like to see published in Asian Journal of OPHTHALMOLOGY, you can make this truly your Journal.

Please send your contributions to:


The Editor
Asian Journal of OPHTHALMOLOGY
Scientific Communications (Hong Kong) Ltd
4/F, 11 Queen Victoria Street
Central
Hong Kong
 

 

Tel:
Fax:

 

 





Home - Table of Contents - Editorial Board